2024 |
Tenaya Therapeutics Inc
|
Independent Director |
98.3 K |
-51.4 % |
2024 |
Anebulo Pharmaceuticals Inc
|
Independent Director |
500.0 |
-50.0 % |
2024 |
Evolus Inc
|
Independent Director |
- |
- |
2023 |
Evolus Inc
|
Independent Director |
249.0 K |
4.5 % |
2023 |
Tenaya Therapeutics Inc
|
Independent Director |
202.4 K |
74.3 % |
2023 |
Anebulo Pharmaceuticals Inc
|
Independent Director |
1 K |
-98.9 % |
2022 |
Evolus Inc
|
Independent Director |
238.2 K |
16.5 % |
2022 |
Tenaya Therapeutics Inc
|
Independent Director |
116.1 K |
-63.3 % |
2022 |
Anebulo Pharmaceuticals Inc
|
Independent Director |
90 K |
34.4 % |
2021 |
Arcturus Therapeutics Holdings Inc
|
- |
356.4 K |
59.1 % |
2021 |
Tenaya Therapeutics Inc
|
Independent Director |
316.4 K |
- |
2021 |
Evolus Inc
|
Independent Director |
204.5 K |
4.7 % |
2021 |
Anebulo Pharmaceuticals Inc
|
Independent Director |
67.0 K |
- |
2021 |
Arcturus Therapeutics Holdings Inc
|
Director |
- |
- |
2020 |
Arcturus Therapeutics Holdings Inc
|
Director |
224.1 K |
-5.5 % |
2020 |
Evolus Inc
|
Independent Director |
195.3 K |
-21.4 % |
2020 |
Anebulo Pharmaceuticals Inc
|
Independent Director |
- |
- |
2019 |
Evolus Inc
|
Independent Director |
248.5 K |
- |
2019 |
Arcturus Therapeutics Holdings Inc
|
Director |
237.1 K |
- |
2018 |
Arcturus Therapeutics Holdings Inc
|
Director |
- |
- |